Zusammenfassung
Hintergrund
Die Multiviszeraltransplantation (MuTx) ist eine heute etablierte Therapieoption für Patienten mit einem chronischen Mehrorganversagen. Insbesondere die Indikationsstellung, unter Beachtung der Grund- und Nebenerkrankungen des Empfängers, hat einen entscheidenden Einfluss auf das Outcome.
Ziel der Arbeit
Es sollen kombinierte Organtransplantationen in Verbindung mit einer Lebertransplantation beschrieben und Besonderheiten hinsichtlich Indikationsstellung, Technik und Outcome beleuchtet werden.
Material und Methoden
Die Grundlage der vorliegenden Arbeit bilden aktuelle Empfehlungen und eine Literaturrecherche in den medizinisch relevanten Datenbanken. In diesem Artikel wird auf Lebertransplantationen in Kombination mit mindestens einem thorakalen oder abdominellen Organ fokussiert. Hauptaugenmerk liegt auf der Darstellung operationsspezifischer Besonderheiten und des Outcomes.
Ergebnisse
Das Spektrum der Indikationen für eine MuTx ist heterogen und die Indikationsstellung eine patientenspezifische Einzelfallentscheidung. Die simultane Leber- und Nierentransplantation ist die am häufigsten durchgeführte kombinierte Organtransplantation. Das Langzeitüberleben nach Multiorgantransplantation ist durchschnittlich geringer als bei Patienten nach einer isolierten Lebertransplantation. Im Langzeitverlauf zeigen sich organspezifische Unterschiede. Patienten nach einer simultanen Leber-Nieren-Transplantation erreichen ein 5‑Jahres-Überleben von 86 %, wohingegen z. B. nur 63 % der Patienten nach einer kombinierten Leber- und Lungentransplantation die ersten 3 Jahre überleben.
Diskussion
Die Indikation zur Multiorgantransplantation ist eine Individualentscheidung. Aufgrund der komplexen Grund- und Nebenerkrankungen ist ein Vergleich der postoperativen Morbidität und Mortalität mit der Einzelorgantransplantation nicht möglich.
Abstract
Background
Multivisceral transplantation (MuTx) is an established method for patients suffering from chronic multiorgan failure. The main influence on the outcome after MuTx comes from the indication, considering the underlying disease as well as the recipient-specific comorbidities.
Objectives
Illustrating simultaneous solid organ transplantations evermore in combination with a liver transplantation as well as describing special characteristics regarding indication, technique, and outcome is the main aim of this publication.
Materials and methods
A systematic review was performed utilizing Medline (PubMed), Embase, and the current guidelines for standard of care in transplantation medicine until January 31, 2019. Special attention is given to liver transplantation in combination with at least one thoracic or abdominal organ in this article. The main issue is to identify procedure-specific characteristics and postoperative outcomes.
Results
The rationale for taking MuTx into consideration for a patient as one or maybe the only treatment option varies. Combined liver and kidney transplantation is the most frequently performed simultaneous solid organ transplant. Invariable long-term graft and patient survival after MuTx is reduced compared to single organ transplantation. Organ-specific differences typically appear in long-term follow-up. While patients after simultaneous liver and kidney transplantation attain a 5-year survival rate of 86%, only 63% of all patients after simultaneous liver and lung transplants survive more than 3 years.
Conclusion
The indication for MuTx is always an individual decision. Due to the complexity of the underlying disease in combination with the comorbidities of patients after MuTx, a reliable comparison with single organ transplantation is not feasible either for postoperative morbidity or for mortality.
Literatur
Starzl TE, Bilheimer DW, Bahnson HT, Shaw BW, Hardesty RL, Griffith BP, Iwatsuki S, Zitelli BJ, Gartner JC, Malatack JJ (1984) Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet 1(8391):1382–1383
Health Resources and Services Administration, U.S. Department of Health & Human Services (2019) Organ Procurement and Transplantation Network: Uses of data. https://optn.transplant.hrsa.gov/data/about-data/uses-of-data/. Zugegriffen: 13.03.2019
Eurotransplant (2017) Statistical Report 2017. 1. Eurotransplant: Donation, waiting lists and transplants
Cannon RM, Hughes MG, Jones CM, Eng M, Marvin MR (2012) A review of the United States experience with combined heart-liver transplantation. Transpl Int 25(12):1223–1228
Belghiti J, Panis Y, Sauvanet A, Gayet B, Fékété F (1992) A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet 175(3):270–272
Rauchfuss F, Breuer M, Dittmar Y, Heise M, Bossert T, Hekmat K, Settmacher U (2011) Implantation of the liver during reperfusion of the heart in combined heart-liver transplantation: Own experience and review of the literature. Transplant Proc 43(7):2707–2713
Hill AL, Maeda K, Bonham CA, Concepcion W (2012) Pediatric combined heart-liver transplantation performed en bloc: A single-center experience. Pediatr Transplant 16(4):392–397
Barreiros A‑P, Post F, Hoppe-Lotichius M, Linke RP, Vahl CF, Schäfers H‑J, Galle PR, Otto G (2010) Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: A single-center experience. Liver Transpl 16(3):314–323
Barrio IM, Mtnez de Guereñu MA, Real MI, Del Campo I, Pérez-Cerdá F, Moreno E (2007) Anesthetic management of a combined heart and liver transplantation in an amyloidotic patient: A case report. Transplant Proc 39(7):2458–2459
Pilato E, Dell’Amore A, Botta L, Arpesella G (2007) Combined heart and liver transplantation for familial amyloidotic neuropathy. Eur J Cardiothorac Surg 32(1):180–182
Bryant R, Rizwan R, Zafar F, Shah SA, Chin C, Tweddell JS, Morales DL (2018) Contemporary outcomes of combined heart-liver transplant in patients with congenital heart disease. Transplantation 102(2):e67–e73
Atluri P, Gaffey A, Howard J, Phillips E, Goldstone AB, Hornsby N, MacArthur JW, Cohen JE, Gutsche J, Woo YJ (2014) Combined heart and liver transplantation can be safely performed with excellent short- and long-term results. Ann Thorac Surg 98(3):858–862
Freischlag K, Schroder PM, Ezekian B, Cox ML, Mulvihill MS, Hartwig MG, Knechtle SJ (2018) Improved survival in simultaneous lung-liver recipients and candidates in the modern era of lung allocation. J Surg Res 231:395–402
Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, Coke MA, Garrity ER, Sweet SC, Heiney DA, Grover FL (2006) Development of the new lung allocation system in the United States. Am J Transplant 6(5p2):1212–1227
Barshes NR, DiBardino DJ, McKenzie ED, Lee TC, Stayer SA, Mallory GB, Karpen SJ, Quiros-Tejeira RE, Carter BA, Fraser CD, Goss JA (2005) Combined lung and liver transplantation: The United States experience. Transplantation 80(9):1161–1167
Barbara D, Rehfeldt K, Heimbach J, Rosen C, Daly R, Findlay J (2014) Perioperative management of patients undergoing combined heart-liver transplantation. Crit Care 18(1):P205
Daly AB, Wallis JM, Borg ZD, Bonvillain RW, Deng B, Ballif BA, Jaworski DM, Allen GB, Weiss DJ (2012) Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A 18(1/2):1–16
Ceulemans LJ, Monbaliu D, Verslype C, van der Merwe S, Laleman W, Vos R, Neyrinck A, Van Veer H, De Leyn P, Nevens F, Pirenne J, Verleden G, Van Raemdonck D (2014) Combined liver and lung transplantation with extended normothermic lung preservation in a patient with end-stage emphysema complicated by drug-induced acute liver failure. Am J Transplant 14(10):2412–2416
Arnon R, Annunziato RA, Miloh T, Padilla M, Sogawa H, Batemarco L, Willis A, Suchy F, Kerkar N (2011) Liver and combined lung and liver transplantation for cystic fibrosis: Analysis of the UNOS database. Pediatr Transplant 15(3):254–264
Kornberg A, Küpper B, Bärthel E, Tannapfel A, Müller UA, Thrum K, Kloos C, Wolf G (2009) Combined en-bloc liver-pancreas transplantation in patients with liver cirrhosis and insulin-dependent type 2 diabetes mellitus. Transplantation 87(4):542–545
Vianna R, Beduschi T (2016) Multivisceral transplantation for diffuse splanchnic venous thrombosis. Curr Opin Organ Transplant 21(2):201–208
Farmer DG, McDiarmid SV, Edelstein S, Yersiz H, Vargas J, Cortina G, Renz JF, Fondevila C, Hisatake G, Reyen L, Correa M, Rhodes S, Zafar A, Chavez Y, Busuttil RW (2004) Improved outcome after intestinal transplantation at a single institution over 12 years. Transplant Proc 36(2):303–304
Müller AR, Pascher A, Platz K‑P, Neuhaus P (2003) Small bowel transplantation—Current status and initial results. Zentralbl Chir 128(10):849–855
Starzl TE, Rowe MI, Todo S, Jaffe R, Tzakis A, Hoffman AL, Esquivel C, Porter KA, Venkataramanan R, Makowka L (1989) Transplantation of multiple abdominal viscera. JAMA 261(10):1449–1457
Starzl TE, Todo S, Tzakis A, Podesta L, Mieles L, Demetris A, Teperman L, Selby R, Stevenson W, Stieber A (1989) Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 210(3):374–385 (discussion 385–386)
Young AL, Peters CJ, Toogood GJ, Davies MH, Millson CE, Lodge JPA, Pollard SG, Prasad KR (2005) A combined liver-pancreas en-bloc transplant in a patient with cystic fibrosis. Transplantation 80(5):605–607
Trotter JF, Bak TE, Wachs ME, Everson GT, Kam I (2000) Combined liver-pancreas transplantation in a patient with primary sclerosing cholangitis and insulin-dependent diabetes mellitus. Transplantation 70(10):1469–1471
Mayes JT, Boyle JT, Schulak JA (1991) Simultaneous orthotopic liver and heterotopic pancreas transplantation. Transplantation 52(1):146–147
Schnitzbauer AA, Woeste G, Ulrich F, Bechstein WO (2012) Indikationen und Komplikationen bei Multiorgantransplantationen. Viszeralmedizin 28(5):324–329
Bandsma RHJ, Bozic MA, Fridell JA, Crull MH, Molleston J, Avitzur Y, Mozer-Glassberg Y, Gonzalez-Peralta RP, Hodik M, Fecteau A, de Angelis M, Durie P, Ng VL (2014) Simultaneous liver-pancreas transplantation for cystic fibrosis-related liver disease: A multicenter experience. J Cyst Fibros 13(4):471–477
Miguel M, Andres AM, Lopez-Santamaria M, Barrena S, Hierro L, Hernandez F, Ramírez M, Frauca E, Encinas JL, Lopez-Fernandez S, Jara P, Tovar JA (2012) Liver transplantation in children with cystic fibrosis: Experience in our centre and preliminary results with a combined en bloc liver-pancreas graft. Eur J Pediatr Surg 22(1):60–66
Pirenne J, Aerts R, Yoong K, Gunson B, Koshiba T, Fourneau I, Mayer D, Buckels J, Mirza D, Roskams T, Elias E, Nevens F, Fevery J, McMaster P (2001) Liver transplantation for polycystic liver disease. Liver Transpl 7(3):238–245
Seckinger J, Tönshoff B, Stremmel W, Zeier M, Schmidt J (2010) Combined liver-kidney and kidney after liver transplantation: Indications and experiences from a nephrological perspective at a single center. Dtsch Med Wochenschr 135(40):1973–1978
Margreiter R, Kramar R, Huber C, Steiner E, Niederwieser D, Judmaier G, Vogel W (1984) Combined liver and kidney transplantation. Lancet 1(8385):1077–1078
Jochmans I, Monbaliu D, Ceulemans LJ, Pirenne J, Fronek J (2017) Simultaneous liver kidney transplantation and (bilateral) nephrectomy through a midline is feasible and safe in polycystic disease. PLoS ONE 12(3):1–10
Gunabushanam V, Clendenon J, Aldag E, Chadha M, Kramer D, Steers J, Sahajpal A (2016) En bloc liver kidney transplantation using donor splenic artery as inflow to the kidney: Report of two cases. Am J Transplant 16(10):3046–3048
Felgendreff P, Tautenhahn H-M, Lux S, Schindler C, Dondorf F, Aschenbach R, Rauchfuß F, Settmacher U (2018) Simultaneous right-sided nephrectomy with orthotopic liver/kidney transplantation—An alternative method for patients with ADPLKD. in preparation
Puri V, Eason J (2015) Simultaneous liver-kidney transplantation. Curr Transplant Rep 2(4):297–302
Bundesärztekammer (2010) Richtlinien für die Wartelistenführung und die Organvermittlung zur Nierentransplantation
Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, Mulligan D (2016) Simultaneous liver-kidney allocation policy: A proposal to optimize appropriate utilization of scarce resources. Am J Transplant 16(3):758–766
Oppert M, Neumann U, Pascher A, Storm C, Lang T, Neuhaus R, Frei U, Neuhaus P, Kahl A (2010) Langzeitüberleben nach kombinierter Leber- und Nierentransplantation. Transplantationsmedizin 22(3):170–175
Kirchner GI, Rifai K, Cantz T, Nashan B, Terkamp C, Becker T, Strassburg C, Barg-Hock H, Wagner S, Lück R, Klempnauer J, Manns MP (2006) Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation. Liver Transpl 12(8):1268–1277
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Felgendreff, H.-M. Tautenhahn, F. Dondorf, F. Rauchfuß und U. Settmacher geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
G. Gerken, Essen
S. Zeuzem, Frankfurt am Main
Rights and permissions
About this article
Cite this article
Felgendreff, P., Tautenhahn, HM., Dondorf, F. et al. Multiviszeraltransplantationen – Indikationen, Technik und Outcome. Gastroenterologe 14, 282–288 (2019). https://doi.org/10.1007/s11377-019-0350-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11377-019-0350-5